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Background: The impact of percutaneous coronary intervention (PCI) for chronic
total occlusion (CTO) in patients with smoking history is not clear. Smoking history is
known to have an adverse effect on clinical outcomes of coronary artery diseases. We
evaluated the 12-month clinical outcomes between PCI and optimal medical therapy
(OMT) for CTO lesions in patients with smoking history.
Methods: A total of 321 consecutive CTO patients with smoking history were divided
into 2 groups according to treatment strategy; PCI group (n¼145) and OMT group
(n¼176). Twelve–month clinical outcomes were retrospectively compared between
the two groups.
Results: At baseline, patients in the OMT group had a lower left ventricular ejection
fraction, and higher prevalence of elderly, cerebrovascular accident, peripheral
vascular disease, congestive heart failure, left main disease, multivessel disease, right
coronary artery CTO lesion, and collaterals grade 2. Clinical outcomes at 12 months
were similar between the 2 groups except lower mortality in the PCI group at uni-
variate analysis. After baseline adjustment by multivariate analysis, 12-month mor-
tality remained lower in the PCI group (OR 0.112, 95% CI 0.014-0.910, p¼0.041)
despite of increased target lesion revascularization (TLR) in the PCI group (table).
Conclusion: In our study, PCI seems to be a favorable choice of therapy for CTO
lesions in patients with smoking history in terms of reducing 12-month mortality.
Long-term follow up with a larger study population will be necessary for further
clariﬁcation.TCTAP A-176
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Background: There have been many studies regarding acetylcholine (Ach) induced
coronary artery spasm (CAS). However, although spastic coronary artery at baseline
coronary angiography is common in clinical practice, clinical outcomes according to
the response to Ach in patients with basal CAS are unknown.
Methods: A total of 728 patients without signiﬁcant coronary lesion who had spastic
coronary angiogram at baseline before Ach test deﬁned as % narrowing difference
>30% following intracoronary nitroglycerine injection were enrolled between
November 2004 and October 2010. Patients were divided into two groups according
to the response to the acetylcholine test (Ach responder group: n¼495, Ach non-S50 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstractsresponder group: n¼233) and clinical outcomes were compared between the two
groups up to 3 years.
Results: Baseline characteristics were matched using propensity score matching.
Ischemic ECG change during Ach test was more frequent in Ach responder group
(p<0.001). There was no signiﬁcant difference in mortality or major adverse
cardiac & cerebrovascular events (MACE) between the two groups. However, the
Ach responder group showed signiﬁcant higher rate of recurrent chest pain which
subsequently needed re-evaluation of coronary artery (OR; 3.05, 95%CI; 1.32-
7.01, p¼0.009). And this difference remained signiﬁcant after multivariate anal-
ysis of other cardiovascular risk factors (OR; 3.22, 95%CI; 1.43-7.27, p¼0.005,
Fig 1).
Conclusion: Ach responsive patients who had increase coronary spastic tone was
associated with recurrent chest pain and higher rate of follow up coronary angiog-
raphy. Therefore, more intensive anti-spastic medication and close clinical follow up
would be needed for these patients.TCTAP A-177
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Background: Metabolic Syndrome (MS) has been known to be an important car-
diovascular risk factor. We investigated whether the presence of MS can impact on
coronary artery spasm (CAS) as assessed with intracoronary acetylcholine (Ach)
provocation test.
Methods: A total 3490 consecutive patients (pts) who underwent coronary angiog-
raphy with Ach provocation test were enrolled. National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP-ATP III) was used for the deﬁnition of the
MS. The pts were divided into two groups; MS group (n¼680,19.5%) and non-MS
group (n¼2810, 80.5%) groups. Ach provocation test was performed by incremental
dosage (20, 50, 100ug) into left coronary artery. Signiﬁcant CAS was deﬁned more
than >70% luminal narrowing visually with chest pain with/without ST segment
changes.
Results: Baseline characteristics were balanced between the two groups except the
MS group had more elderly, hypertension, diabetes, dyslipidemia, and cerebro-
vascular accident, whereas the male gender, peripheral vascular disease, current
smoking and alcohol were lower in the MS group. Angiography characteristics
during Ach provocation test, the MS group showed higher incidence of QCA
measured severe CAS, mean % narrowing and smaller mean diameter than non-MS
group (Table).
Conclusion: According to our study, the MS pts had more coronary risk factors and
worse angiographic characteristics during Ach provocation test, suggesting more
careful medical therapy and follow up would be required./POSTER/High Risk Patients: Diabetes, Heart Failure, Renal Failure, Others
